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Genomic information is becoming increas-
ingly important in healthcare with possible 
uses including the personalization of preven-
tion and treatment recommendations and 
motivation for health behavior change [1]. 
In order to translate genomic information 
effectively to clinical and public health con-
texts, we need to understand how individu-
als from different population subgroups use 
this information as costly or complicated 
advances may in fact exacerbate health dis-
parities. Thus, a critical issue as the integra-
tion of genomic information expands will 
be to investigate use of and responses to this 
information across racial and ethnic groups 
to avoid widening existing disparities in 
access to and uptake of health information 
and services that impact health outcomes [1].
In a previous study, we found evidence 
that race and ethnicity affect responses to 
information about genomic risk for common, 
chronic conditions in a medically underserved 
patient population. Participants viewed a 
hypothetical vignette that presented risk for 
either heart disease or diabetes following 
a genomic assessment. We found that non-
Hispanic black participants had significantly 
greater interest in discussing the genomic risk 
information with a doctor compared with 
white participants, and both non-Hispanic 
black and Hispanic participants had greater 
interest in discussing the information with 
family than white participants. In addition 
to these communication responses, black 
and Hispanic participants reported that they 
intended to change fewer health behaviors 
than white participants based on the infor-
mation, although Hispanic participants were 
more interested in receiving a genomic assess-
ment than white participants [2]. These find-
ings therefore suggested that both interest in 
accessing genomic information and resulting 
behavioral responses may differ by race and 
ethnicity. Although the research base is lim-
ited, other studies have also examined how 
race and ethnicity might affect responses to 
genomic information. For example, a study 
investigating use of risk reduction strate-
gies following genetic counseling and test-
ing for BRCA1 among female members of 
an African–American kindred showed that 
surveillance was preferred to prophylactic 
surgery and chemoprevention for cancer risk 
reduction. The findings also revealed sub-
optimal provider–patient communication 
in this patient group [3]. The evidence in 
this area suggests that responses to genomic 
information may vary by race and ethnic-
ity, and that factors such as provider–patient 
communication about the information may 
contribute to these differences.
Related work has suggested that individu-
als from minority racial and ethnic groups 
may be less likely to access and use genetic 
testing and, therefore, genomic information. 
For example, a number of studies have shown 
lower use of genetic testing among individu-
als from racial and ethnic minority groups 
Importance of race and ethnicity in 




Huntsman Cancer Institute, University 
of Utah, Salt Lake City, UT 84112, USA
and 
Department of Communication, 
University of Utah, Salt Lake City, 
UT 84112, USA 
Tel.: +1 801 213 5724  
kim.kaphingst@hci.utah.edu
Melody S Goodman
Division of Public Health Sciences, 
Washington University School of 
Medicine, St Louis, MO 63110, USA
“Both individual- and system-level factors likely contribute to 
differences by race and ethnicity in use of and responses to genomic 
information.” 
For reprint orders, please contact: reprints@futuremedicine.com
10.2217/pme.15.39 Per. Med. (Epub ahead of print) future science group
Editorial    Kaphingst & Goodman
compared with whites [4]. Interestingly, disparities in 
use remain even when barriers of ascertainment and 
cost are minimized, suggesting that both access and 
decisions to use genetic services may differ by race 
and ethnicity. Among a population-based sample of 
healthy adults aged 25–40 years with access to health-
care in the USA, African–American individuals were 
less likely to opt to receive a free multiplex genetic sus-
ceptibility test [5]. A recent randomized trial compar-
ing mode of delivery of genetic counseling (in-person 
vs telephone-based) for hereditary breast and ovarian 
cancer at multiple USA sites found that the effect of 
mode of delivery differed by race; minority women 
assigned to telephone counseling were the least likely 
to complete genetic testing [6].
A number of possible mechanisms underlying racial 
and ethnic differences in access to and use of genomic 
information and responses to this information have 
been advanced, including both individual- and system-
level factors. Individual-level factors identified include 
awareness, knowledge, attitudes and beliefs. A number 
of prior studies have suggested that individuals from 
minority racial and ethnic groups have lower knowl-
edge about and more negative attitudes related to 
genetic testing, which could affect both use of genetic 
services and responses to the information [7,8]. How-
ever, some contradictory evidence has been found. 
A national telephone survey of US adults showed 
that although there were some differences in genetic 
knowledge by racial and ethnic group, many misun-
derstandings about genetic concepts were shared across 
groups [9]. Negative attitudes may be due in part to lack 
of awareness or knowledge. In a focus group study with 
Latinos, awareness of familial breast and ovarian cancer 
and availability of genetic services were low, but after 
participants received information they held favorable 
attitudes toward genetic services [10]. Culture is likely 
to play a critical role in shaping individuals’ awareness, 
beliefs and attitudes about genomic information. Cul-
tural differences in fatalism, temporal orientation, spir-
ituality and beliefs about illness and prevention might 
affect differences in use of and responses to genomic 
information across racial and ethnic groups [11]. Accul-
turation has also been shown to affect awareness of 
and attitudes toward genetic testing among Latinos [7]. 
Disentangling how these various individual level fac-
tors affect each other, and how culture influences these 
factors, will be critical to understanding differences in 
downstream outcomes by race and ethnicity.
Although more research has investigated how indi-
vidual-level factors might affect use of and responses 
to genomic information, a few studies have pointed to 
the importance of system-level factors. In an investiga-
tion of providers’ perceptions of genetic counseling and 
testing for BRCA1/2 in African–American women, 
providers identified both individual- and system-level 
barriers to use of genetic services [12]. Healthcare sys-
tem barriers such as insurance barriers might impact 
not only access to genetic services but also responses to 
genomic information if access to healthcare providers 
is impaired. Lower levels of trust in the healthcare sys-
tem among individuals from minority racial and eth-
nic groups may lead to greater concerns about misuse 
of genetic information and racial discrimination based 
on genetic testing [8,11].
Both individual- and system-level factors likely con-
tribute to differences by race and ethnicity in use of 
and responses to genomic information. A recent cross-
sectional survey of women diagnosed with nonmeta-
static breast cancer showed a strong desire for genetic 
testing among Latinas, but also highlighted that 
minority patients were significantly more likely to have 
an unmet need for discussion of genetic testing with 
providers [13]. Others have called for empirical research 
on disparities in genetic testing that moves beyond 
descriptive studies to differentiate between disparities 
in access to genetic services and differences in use of 
those services that are due to individual preferences 
and cultural values (first-generation health disparities 
research) [14,15]. We would add the importance of mul-
tilevel studies examining how individual- and system-
level factors interact to affect both use of and responses 
to genomic information (second generation). In addi-
tion, we need to move toward higher generations of 
health disparities research in the area of genomics 
to examine the effectiveness of interventions aimed 
to reduce disparities (third generation) and address 
health equity using community-based participatory 
research approaches (fourth generation) [16,17].
A number of additional areas of research are needed 
to better understand how race and ethnicity affect use 
of and responses to genomic information. Our under-
standing of the role of race and ethnicity has been 
hampered by the under representation of individuals 
from minority groups in genetic research [5], and we 
need to develop outreach approaches that are culturally 
appropriate for individuals and communities from dif-
ferent population subgroups. More work is particularly 
needed to understand use of and responses to differ-
ent types of genomic information among population 
subgroups such as Pacific Islanders and Native com-
munities. In addition, exploration of the heterogeneity 
within racial and ethnic groups is critical. One such 
“Such investigations will be critical to translating 
genomic information into healthcare settings and 
disease prevention initiatives in ways that reduce 
rather than exacerbate health disparities.”
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study has indicated important areas of heterogeneity 
within Hispanic subethnicities regarding preferences 
for information about genetic testing [18], but more 
research is needed to build upon this. Heterogeneity 
within racial and ethnic group according to factors 
such as health literacy, numeracy, socioeconomic sta-
tus, country of origin and geographic region are also 
critical to examine. Finally, much of the prior work in 
this area has focused on genetic testing for hereditary 
cancers, and investigations are needed with regard to 
newer technologies with powerful implications for per-
sonalized medicine, such as multigene panels, genome 
sequencing and pharmacogenomics.
Addressing the research gaps outlined above is criti-
cal to the development of effective communication 
approaches to increase appropriate use of genetic ser-
vices and translate research in genomics into improve-
ments in clinical care and public health [1]. Research 
to develop and test culturally appropriate communi-
cation approaches for genomic information has shown 
promise. In a randomized trial comparing culturally 
tailored genetic counseling and standard genetic coun-
seling among African–American women at moderate 
or high risk for BRCA mutations, those who received 
the culturally tailored approach had significantly 
decreased worry [19]. Understanding how differences 
in attitudes toward and knowledge of genomic infor-
mation vary across racial and ethnic groups can also 
assist in developing strategies to support individuals in 
making informed decisions about the use of genomic 
information. Intervention research can investigate how 
effective approaches to assist individuals to understand 
and act upon genomic information might differ across 
racial and ethnic groups [20].
In sum, prior research has shown differences by 
race and ethnicity in use of and responses to genomic 
information. However, many gaps remain and inter-
disciplinary research is needed to fully understand 
these differences and the mechanisms that underlie 
them. Such investigations will be critical to translat-
ing genomic information into healthcare settings and 
disease prevention initiatives in ways that reduce rather 
than exacerbate health disparities.
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